Related Experiment Video
Updated: Aug 30, 2026
Germ Cell Transplantation and Testis Tissue Xenografting in Mice
Published on: February 6, 2012
[Metachronous testicular tumor of an extragonadal germ cell tumor]
A Häcker1, M Hatzinger, T Knoll
1Urologische Universitätsklinik, Klinikum Mannheim gGmbH, Fakultät für Klinische Medizin Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim. axel.haecker@chir.ma.uni-heidelberg.de
Introduction:
Approximately 5 - 7 % of germ cell tumors are of extragonadal origin. Biology and genetics are unclear, especially when the primary location is in the retroperitoneum. Chemotherapy is the initial treatment of choice for extragonadal germ cell tumors (EGGCTs), followed by surgical resection of the residual tumor mass. A primary testicular tumor must be ruled out by sonographic investigation and biopsy. The rate of metachronous testicular cancer in men with primary EGGCT is largely unknown.
Case Report:
We present the first patient in the literature who developed a metachronous testicular cancer 10 months after primary occurrence of EGGCT in the retroperitoneum.
Conclusions:
This case report emphasizes the importance of follow-up examinations of patients with primary EGGCTs. They should include careful sonographic investigation of the testis in order to detect metachronous testicular cancer early. Suspicious findings require open surgery biopsy. Intraoperative histopathology can be false-negative for cancer detection, as an immunohistochemical examination is not available.
Insights
Extragonadal germ cell tumors (EGGCTs) require vigilant follow-up. This case highlights the risk of metachronous testicular cancer, emphasizing the need for regular testicular ultrasounds in EGGCT survivors.
Area of Science:
- Oncology
- Urology
Background:
- Extragonadal germ cell tumors (EGGCTs) constitute 5-7% of germ cell tumors, with unclear biology and genetics, particularly when originating in the retroperitoneum.
- Standard treatment involves chemotherapy followed by surgical resection of residual masses.
- Ruling out primary testicular tumors via sonography and biopsy is crucial.
Observation:
- This report details the first documented case of metachronous testicular cancer developing 10 months after a primary retroperitoneal EGGCT.
Findings:
- The incidence of metachronous testicular cancer in patients with primary EGGCTs remains largely undetermined.
- Intraoperative histopathology may yield false-negative results due to the absence of immunohistochemical examination.
Implications:
- Regular follow-up examinations for EGGCT patients are essential.
- These follow-ups must include thorough testicular sonography to enable early detection of metachronous testicular cancer.
- Suspicious findings warrant open surgical biopsy for accurate diagnosis.
